Mutations outside the YMDD motif in the P protein can also cause DHBV resistant to Lamivudine
Jinyang He
openalex +2 more sources
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients [PDF]
Yves Benhamou +8 more
openalex +1 more source
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort. [PDF]
Vergori A +12 more
europepmc +1 more source
Genotype and Phenotype at Baseline and at Failure in Human Immunodeficiency Virus–Infected Antiretroviral‐Naive Patients in a Randomized Trial Comparing Zidovudine and Lamivudine plus Nelfinavir or Nevirapine [PDF]
Elena Ferrer +11 more
openalex +1 more source
Treatment Persistence and Switch Among Medicare-Insured People with HIV and Gaps in Care. [PDF]
Li S +9 more
europepmc +1 more source
Unboosted atazanavir with lamivudine/emtricitabine for patients with long‐lasting virological suppression [PDF]
Alessia Carbone +11 more
openalex +1 more source
Antiviral therapy for various stages of HBV‐related diseases: Lamivudine and beyond [PDF]
Jidong Jia
openalex +1 more source
Real-World Outcomes of Antiretroviral Therapy in People Living With HIV in Saudi Arabia: A Three-Year Observational Cohort Study From a Tertiary Care Center. [PDF]
Alsaeed A.
europepmc +1 more source
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens. [PDF]
Dickinson L +7 more
europepmc +1 more source

